Itzhak Goldberg - 06 Dec 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Executive Chairman and Chief Scientific Officer, Director
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Itzhak Goldberg
Issuer symbol
ELTX
Transactions as of
06 Dec 2021
Net transactions value
-$107,721
Form type
4
Filing time
07 Dec 2021, 15:06:40 UTC
Previous filing
03 Dec 2021
Next filing
11 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Sale $107,721 -32,118 -1.8% $3.35 1,720,068 06 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.21 to $3.45 inclusive.

Remarks:

Executive Chairman and Chief Scientific Officer